InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Greenberg Richard S, 董事长兼首席执行官. Officer active across 1 company, notably Nexien Biopharma, INC.. Cumulatively, 9 disclosures have been published. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Greenberg Richard S is President and Chief Executive Officer and Chief Executive Officer of Nexien Biopharma, INC. He has 9 filings in total, and in the 9 sampled filings the recorded transactions are attribution events, with a date range from 2021-11-29 to 2024-05-28.